These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34581255)

  • 1. Treatment of spinal tuberculosis in rabbits using bovine serum albumin nanoparticles loaded with isoniazid and rifampicin.
    Ma R; Zhang J; Chen Z; Ma H; Liu X; Liang S; Wu P; Ge Z
    Neurol Res; 2022 Mar; 44(3):268-274. PubMed ID: 34581255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and In Vitro Release of Isoniazid and Rifampicin-Loaded Bovine Serum Albumin Nanoparticles.
    Ge Z; Ma R; Xu G; Chen Z; Zhang D; Wang Q; Hei L; Ma W
    Med Sci Monit; 2018 Jan; 24():473-478. PubMed ID: 29364864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic and safety evaluation of the use of ciprofloxacin on an isoniazid-rifampicin regimen in rabbits.
    Padilha EC; Pires RV; Filho MA; de Pontes Machado DV; Baldan HM; Davanço MG; Campos ML; Brunetti IL; Peccinini RG
    Biopharm Drug Dispos; 2012 Dec; 33(9):501-9. PubMed ID: 23007681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous determination of three antituberculosis drugs in the serum of patients with spinal tuberculosis by capillary electrophoresis.
    Wu X; Che X; Qiu Z; Chao J; Kong Z; Li H
    Anal Methods; 2021 Sep; 13(37):4307-4313. PubMed ID: 34473140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo/in vitro pharmacokinetic and pharmacodynamic study of spray-dried poly-(dl-lactic-co-glycolic) acid nanoparticles encapsulating rifampicin and isoniazid.
    Booysen LL; Kalombo L; Brooks E; Hansen R; Gilliland J; Gruppo V; Lungenhofer P; Semete-Makokotlela B; Swai HS; Kotze AF; Lenaerts A; du Plessis LH
    Int J Pharm; 2013 Feb; 444(1-2):10-7. PubMed ID: 23357255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug-induced hepatotoxicity caused by anti-tuberculosis drugs in tuberculosis patients complicated with chronic hepatitis].
    Kaneko Y; Nagayama N; Kawabe Y; Shimada M; Suzuki J; Kunogi M; Matsui Y; Kawashima M; Suzuki J; Ariga H; Oshima N; Masuda K; Matsui H; Nagai H; Tamura A; Akagawa S; Toyoda E; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2008 Jan; 83(1):13-9. PubMed ID: 18283910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of GenoType MTBDRplus for the detection of multi-drug-resistant Mycobacterium tuberculosis strains].
    Chikamatsu K; Mizuno K; Aono A; Yamada H; Sugamoto T; Nishiyama H; Mitarai S
    Kekkaku; 2011 Jul; 86(7):697-702. PubMed ID: 21922778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of rifampin and isoniazid on the pharmacokinetics of diazepam in rabbits].
    Long CF; Zhang Y; Lou YC
    Yao Xue Xue Bao; 1997 Jul; 32(7):481-4. PubMed ID: 11596270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
    Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H
    Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results].
    Fujino T; Hasegawa N; Satou R; Komatsu H; Kawada K
    Kekkaku; 1998 Jul; 73(7):471-6. PubMed ID: 9739579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rifampicin and isoniazid increase acetaminophen and isoniazid cytotoxicity in human HepG2 hepatoma cells.
    Nicod L; Viollon C; Regnier A; Jacqueson A; Richert L
    Hum Exp Toxicol; 1997 Jan; 16(1):28-34. PubMed ID: 9023573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical study on the cases in which INH or RFP was discontinued during treatment for pulmonary tuberculosis].
    Harada S; Takamoto M; Ishibashi T; Mohri M; Sato K; Yamagishi F; Sasaki Y; Tanabe K; Sato R; Fujino T; Tano M; Tanizawa M; Sakatani M; Morimoto T; Kawahara S; Hotta N; Shigeto E; Nishimura K; Abe T; Iwanaga T; Oe T; Shimazu K; Ebihara M; Nakagawa S; Kuba M;
    Kekkaku; 2001 May; 76(5):427-36. PubMed ID: 11449698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of three antituberculous drugs in serum and cold abscesses of patients with spinal tuberculosis].
    Wu Q; Duan L; Lin Y
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Oct; 21(10):617-9. PubMed ID: 11477883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient intermittent rifapentine-moxifloxacin-containing short-course regimen for treatment of tuberculosis in mice.
    Veziris N; Lounis N; Chauffour A; Truffot-Pernot C; Jarlier V
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4015-9. PubMed ID: 16189074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The use of gene chip in detecting Mycobacterium tuberculosis resistant to rifampin and isoniazid].
    Cui ZL; Jing FX; Hu ZY; Wu ZR; Zhao JL
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jul; 27(7):439-41. PubMed ID: 15312553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of the concentration of three antituberculosis drugs in the focus of spinal tuberculosis.
    Ge Z; Wang Z; Wei M
    Eur Spine J; 2008 Nov; 17(11):1482-7. PubMed ID: 18795341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A biphasic nanohydroxyapatite/calcium sulphate carrier containing Rifampicin and Isoniazid for local delivery gives sustained and effective antibiotic release and prevents biofilm formation.
    Qayoom I; Verma R; Murugan PA; Raina DB; Teotia AK; Matheshwaran S; Nair NN; Tägil M; Lidgren L; Kumar A
    Sci Rep; 2020 Aug; 10(1):14128. PubMed ID: 32839480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A bioactive implant in situ and long-term releases combined drugs for treatment of osteoarticular tuberculosis.
    Zhou CX; Li L; Ma YG; Li BN; Li G; Zhou Z; Shi F; Weng J; Zhang C; Wang F; Cui X; Wang L; Wang H
    Biomaterials; 2018 Sep; 176():50-59. PubMed ID: 29857274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Approach to chemotherapy of vertebral tuberculosis].
    Li YD
    Zhonghua Jie He He Hu Xi Za Zhi; 1990 Apr; 13(2):72-3, 125. PubMed ID: 2397533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.